MAIA Biotechnology, Inc.
MAIA· NYSE
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2022 | Q1 2021 |
|---|---|---|
| Net Income | -$3.41M | -$1.53M |
| EPS Diluted | -$0.50 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
MAIA Biotechnology, Inc. · CIK 1878313 · Engraved from SEC EDGAR